Patent ID: 11926653
Assignee: RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 15:
16. The method claim 8, wherein the subject is suffering from a transthyretin amyloid neuropathy, an acquired neuropathy caused by cancer, diabetes mellitus, human immunodeficiency virus (HIV) infection, thyroid disorder, hypothyroidism, hypoglycemia, uremia, renal insufficiency, hepatic dysfunction, hepatic failure, polycythemia, connective tissue disorders, lyme disease, celiac disease, leprosy, porphyria, Sjogren's syndrome, poliomyelitis, acromegaly, disorders of lipid/glycolipid metabolism, West Nile syndrome, amyloidosis, mitochondrial disorders, dysproteinemic disorders, monoclonal gammapathy of undetermined significance (MGUS), POEMS syndrome, nutritional/vitamin deficiency, vitamin B12 deficiency, vitamin E deficiency, copper deficiency, hereditary myopathy, peripheral neuropathy, toxic neuropathy, autoimmune peripheral polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy (AIDP), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), vasculitic mononeuritis multiplex, paraneuropathy, idiopathic ganglionitis, amyotrophic lateral sclerosis, multifocal motor conduction lock neuropathy, lower motor neuron syndrome, neuromuscular disease, muscular atrophy, drug-induced myopathy, sarcopenia, cachexia, type II muscle fiber atrophy, age-related muscular atrophy or an acquired autoimmune primary muscle disorder.